Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gerard T Vondeling"'
Autor:
Kris Rama, Adrianne M de Roo, Timon Louwsma, Hinko S Hofstra, Gabriel S Gurgel do Amaral, Gerard T Vondeling, Maarten J Postma, Roel D Freriks
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 6, p e0012254 (2024)
BackgroundChikungunya is a viral disease caused by a mosquito-borne alphavirus. The acute phase of the disease includes symptoms such as fever and arthralgia and lasts 7-10 days. However, debilitating symptoms can persist for months or years. Despite
Externí odkaz:
https://doaj.org/article/9b7c47ac435d414ba803f600e085a90c
Autor:
Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten J Postma, Roel D Freriks
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 410-418 (2023)
Background Evidence-based reassurances addressing vaccine-related concerns are crucial to promoting primary vaccination, completion of the primary series, and booster vaccination. By summarizing and comparing the reactogenicity of COVID-19 vaccines a
Externí odkaz:
https://doaj.org/article/e584a798b2c6448f8879a90f39106932
Autor:
Emily I. Holthuis, Gerard T. Vondeling, Josephina G. Kuiper, Vincent Dezentjé, Mats Rosenlund, Jetty A. Overbeek, Carolien H.M. van Deurzen
Publikováno v:
Holthuis, E I, Vondeling, G T, Kuiper, J G, Dezentjé, V, Rosenlund, M, Overbeek, J A & van Deurzen, C H M 2022, ' Real-world data of HER2-low metastatic breast cancer : A population based cohort study ', Breast, vol. 66, pp. 278-284 . https://doi.org/10.1016/j.breast.2022.11.003
Breast, 66, 278-284. Churchill Livingstone
Breast, 66, 278-284. Churchill Livingstone
Background: With the introduction of investigational human epidermal growth factor receptor 2 (HER2) targeting treatments, thorough understanding of breast cancer with different HER2 expression levels is critical. The aim of this study was to compare
Autor:
Ashley Jaksa, Anthony Louder, Christina Maksymiuk, Gerard T. Vondeling, Laura Martin, Nicolle Gatto, Eric Richards, Antoine Yver, Mats Rosenlund
Publikováno v:
Value in Health. 25:1967-1976
Autor:
Carol Mansfield, Willings Botha, Gerard T. Vondeling, Kathleen Klein, Kongming Wang, Jasmeet Singh, Michelle D. Hackshaw
Publikováno v:
Breast cancer (Tokyo, Japan). 30(1)
Background We aimed to quantify patients’ benefit-risk preferences for attributes associated with human epidermal growth factor receptor 2 (HER2)-targeted breast cancer treatments and estimate minimum acceptable benefits (MABs), denominated in addi
Autor:
Ashley, Jaksa, Anthony, Louder, Christina, Maksymiuk, Gerard T, Vondeling, Laura, Martin, Nicolle, Gatto, Eric, Richards, Antoine, Yver, Mats, Rosenlund
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 25(12)
The development of accelerated approval programs for high morbidity and unmet need conditions has driven the use of single-arm studies in drug development. Regulatory and health technology assessment (HTA) agencies are recognizing that high-quality e
Publikováno v:
Universidad de Lima
Repositorio Institucional-Ulima
Applied Health Economics and Health Policy
Repositorio Institucional-Ulima
Applied Health Economics and Health Policy
Carta al editor: Vondeling et al. Recientemente han publicado en Applied Health Economics and Health Policy (AHEHP) una revisión sistemática (SR) sobre el impacto de la caducidad de la patente en los precios de los medicamentos (original y genéric
Autor:
Lee Bennett, Kaku Saito, Kohei Shitara, Yung-Jue Bang, Gerard T. Vondeling, Michelle D Hackshaw, Diana Garbinsky, Masahiro Sugihara, David Cella, Kensei Yamaguchi
Publikováno v:
Journal of Clinical Oncology. 39:4057-4057
4057 Background: DESTINY-Gastric01 (NCT03329690) is a randomized, phase 2 study evaluating trastuzumab deruxtecan (T-DXd) in patients with HER2-positive advanced gastric cancer who progressed after ≥2 regimens. T-DXd significantly improved objectiv